Highlights
- Market Cap
- $2.40B
- Enterprise Value
- $2.34B
- EPS (TTM)
- $0.78
- PE Ratio
- 48.52
- PEG Ratio
- 1.17
- Total Revenue (TTM)
- $1.45B
- Gross Profit (TTM)
- $292.72M
- EBITDA (TTM)
- $91.16M
- Year Range
- $19.17 - $38.34
- Target Price
- $33.33
- ROA (TTM)
- 11.93%
- ROE (TTM)
- 22.59%
Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Guardian Pharmacy Services, Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
Guardian Pharmacy Services, Inc (GRDN) has returned 25.16% so far this year and 77.14% over the past 12 months.
Guardian Pharmacy Services, Inc
- 1D
- 1.10%
- 1M
- 12.38%
- YTD
- 25.16%
- 6M
- 43.58%
- 1Y
- 77.14%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
Based on dividend-adjusted daily data since Sep 26, 2024, GRDN's average daily return is +0.28%, while the average monthly return is +5.43%. At this rate, your investment would double in approximately 1.1 years.
Historically, 74% of months were positive and 26% were negative. The best month was Nov 2024 with a return of +39.3%, while the worst month was Dec 2024 at -18.8%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 1 months.
On a daily basis, GRDN closed higher 54% of trading days. The best single day was Aug 12, 2025 with a return of +13.8%, while the worst single day was May 21, 2025 at -16.8%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.37% | 10.96% | 12.38% | 25.16% | |||||||||
| 2025 | 12.59% | -12.32% | 6.30% | 17.78% | -15.46% | 0.66% | -1.92% | 26.41% | -0.72% | 6.90% | 4.42% | 2.77% | 48.52% |
| 2024 | 5.00% | 6.61% | 39.25% | -18.77% | 26.63% |
Benchmark Metrics
Guardian Pharmacy Services, Inc has an annualized alpha of 84.61%, beta of 0.82, and R² of 0.08 versus S&P 500 Index. Calculated based on daily prices since September 27, 2024.
- This stock captured 265.44% of S&P 500 Index gains and tended to rise during its downturns (downside capture of -147.11%) — a profile typical of hedging or uncorrelated assets.
- R² of 0.08 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 84.61%
- Beta
- 0.82
- R²
- 0.08
- Upside Capture
- 265.44%
- Downside Capture
- -147.11%
Return for Risk
Risk / Return Rank
GRDN ranks 84 for risk / return — in the top 84% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Guardian Pharmacy Services, Inc (GRDN) and compare them to a chosen benchmark (S&P 500 Index).
| GRDN | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.72 | 0.90 | +0.82 |
Sortino ratioReturn per unit of downside risk | 2.22 | 1.39 | +0.84 |
Omega ratioGain probability vs. loss probability | 1.31 | 1.21 | +0.10 |
Calmar ratioReturn relative to maximum drawdown | 3.36 | 1.40 | +1.97 |
Martin ratioReturn relative to average drawdown | 7.00 | 6.61 | +0.40 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Explore GRDN risk-adjusted metrics in detail
Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the Guardian Pharmacy Services, Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Guardian Pharmacy Services, Inc was 27.21%, occurring on Mar 6, 2025. Recovery took 40 trading sessions.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -27.21% | Dec 13, 2024 | 55 | Mar 6, 2025 | 40 | May 2, 2025 | 95 |
| -25.83% | May 20, 2025 | 20 | Jun 17, 2025 | 52 | Sep 2, 2025 | 72 |
| -22.74% | Sep 12, 2025 | 21 | Oct 10, 2025 | 22 | Nov 11, 2025 | 43 |
| -14.33% | Nov 13, 2025 | 44 | Jan 16, 2026 | 10 | Feb 2, 2026 | 54 |
| -11.01% | Nov 12, 2024 | 2 | Nov 13, 2024 | 7 | Nov 22, 2024 | 9 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Guardian Pharmacy Services, Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Guardian Pharmacy Services, Inc is priced in the market compared to other companies in the Medical Care Facilities industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for GRDN, comparing it with other companies in the Medical Care Facilities industry. Currently, GRDN has a P/E ratio of 48.5. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for GRDN compared to other companies in the Medical Care Facilities industry. GRDN currently has a PEG ratio of 1.2. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for GRDN relative to other companies in the Medical Care Facilities industry. Currently, GRDN has a P/S ratio of 1.6. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for GRDN in comparison with other companies in the Medical Care Facilities industry. Currently, GRDN has a P/B value of 11.0. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |